Epilepsy and Seizure News
Neurofeedback News
What Is Neurofeedback Therapy? -
Neurofeedback is a noninvasive form of therapy that trains the brain to improve various neurological issues, including chronic pain, ADHD, anxiety, depression and PTSD. Using EEG to monitor real-time ...
Elite athletes enhance their performance with 'neurofeedback'—and you can get a device for $99 -
When you think of the training tools that professional athletes have at their disposal, high-tech sports equipment and state-of-the-art athletic facilities come to mind. But training for peak ...
What Is Neurofeedback Therapy And How Does It Work? -
Ashwini Nadkarni, M.D., is a board-certified psychiatrist, Assistant Professor at Harvard Medical School and Interim Vice Chair for Faculty Affairs in the Department of Psychiatry at Brigham and Women ...
Systematic Review Finds Few Active Controlled Benefits in Athlete Neurofeedback Studies -
A systematic review of 56 athletic neurofeedback studies reveals that while positive outcomes are widely reported, only 18 percent demonstrate benefits over active control groups.
What Is Neurofeedback? -
Whenever I mention that neurofeedback helped me regain my life after my multiple brain injuries — or that I’m now a neurofeedback provider — the first reaction is to ask me, what is neurofeedback? I’m ...
Medical News Today
PubMed
Targeting Seizures and Neurobehavioral Alterations: Efficacy of Brivaracetam-Sertraline Combination in PTZ-Induced Kindling Model -
Epilepsy is a neurological disorder associated with various psychiatric comorbidities, among which anxiety and depressive disorders are most prevalent. These psychiatric comorbidities remain frequently untreated due to concerns about exacerbation of seizures and limited awareness about antidepressant selection. This study aimed to evaluate the efficacy of brivaracetam (BRV) and sertraline (SRT)...
Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort -
CONCLUSIONS: IEM should be systematically considered in any child presenting with epilepsy, particularly when onset occurs in the first three years of life. A structured stepwise diagnostic approach can substantially reduce diagnostic delay and facilitate access to disease-specific therapies.
Ictal 18F-FDG PET/CT Findings in Clinically Silent Seizures Caused by a Frontoethmoidal Nasal Meningoencephalocele -
A 55-year-old man presented with a 5-year history of drug-resistant epilepsy with monthly clinical seizures. Investigation revealed a left frontoethmoidal nasal meningoencephalocele secondary to osseous fibrous dysplasia. Video-EEG failed to capture scalp epileptiform activity, but a concomitant intranasal electrode recorded frequent, clinically silent electrographic seizures. This continuous i...
Novel gene therapy lets drug dampen brain cell activity, reducing seizures -
In first clinical result using "chemogenetic" strategy, a team in China treated three patients to control epilepsy.
Functional characterization and pharmacochaperone rescue of a novel SLC6A1 variant associated with developmental epileptic encephalopathies -
Mutations in SLC6A1, encoding the γ-aminobutyric acid (GABA) transporter 1 (GAT-1), are associated with a spectrum of neurodevelopmental disorders, including epilepsy syndromes, intellectual disability (ID), and autism. An important question is whether the impact of these mutations can be predicted at scale using artificial intelligence (AI), and how such predictions correlate with experimental...
Sudden Unexpected Death in Epilepsy: Mechanisms, Biomarkers, and Unanswered Questions -
PURPOSE OF REVIEW: Sudden unexpected death in epilepsy (SUDEP) remains the leading cause of epilepsy-related mortality. While heterogeneous in its pathophysiology, a significant proportion of cases are likely attributable to cardiorespiratory collapse following a convulsive seizure. We synthesize recent mechanistic, biomarker, and prevention literature, moving from retrospective risk inference ...
Science Daily